Solid Biosciences (SLDB) Preferred Dividend Payments (2017)
Solid Biosciences (SLDB) posted Preferred Dividend Payments of $959000.0 for Q1 2017.
Powered by 
Analysis
Solid Biosciences (SLDB) Preferred Dividend Payments (2017) Analysis & Trends
Solid Biosciences has reported Preferred Dividend Payments for 1 years, with the latest figure at $959000.0 in Q1 2017.
- Quarterly Preferred Dividend Payments changed N/A year-over-year to $959000.0 in Q1 2017, while the trailing twelve-month figure through Dec 2017 was $959000.0 (changed N/A YoY) and the FY2017 annual result came in at $959000.0, up 122.26% from the prior year.
- Preferred Dividend Payments held at $959000.0 in Q1 2017 per SLDB's latest filing.
- Over five years, Preferred Dividend Payments peaked at $959000.0 in Q1 2017 and troughed at $959000.0 in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Solid Biosciences | 1.48 Bn | 1.48 Bn | - | - |